Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BMP10 Antikörper (AA 86-96)

BMP10 Reaktivität: Human EIA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN114067
  • Target Alle BMP10 Antikörper anzeigen
    BMP10 (Bone Morphogenetic Protein 10 (BMP10))
    Bindungsspezifität
    • 15
    • 7
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 86-96
    Reaktivität
    • 55
    • 26
    • 25
    • 5
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    Human
    Wirt
    • 48
    • 7
    • 1
    • 1
    Kaninchen
    Klonalität
    • 51
    • 6
    Polyklonal
    Konjugat
    • 35
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BMP10 Antikörper ist unkonjugiert
    Applikation
    • 50
    • 17
    • 14
    • 13
    • 8
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Enzyme Immunoassay (EIA)
    Spezifität
    Bone Morphogenetic Protein 10 (BMP-10) 86-96.
    Aufreinigung
    Ammonium sulphate fractionation
    Immunogen
    KLH conjugate, sequence: C-L-D-K-G-V-V-T-Y-K-F-K
    Top Product
    Discover our top product BMP10 Primärantikörper
  • Applikationshinweise
    Peptide-ELISA: 1/50 - 1/200. In a simple ELISA using 1 g of antigen coated per well, the50 % OD was observed at an antibody dilution of 1/100. With 1 g of peptide-BSA coatedper well the 50 % OD was observed at 1/2500. Under the same conditions the end pointwas observed at 1/80K. Competitive ELISA: pep-BSA plates, coated at 1 g/well, antibodydiluted 1/10K. Pep-BSA displaces in the range 0.1 to 100 μg/mL. The free peptide does notdisplace in this assay system.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1.8 mg/mL (OD280)
    Buffer
    PBS, pH 7.2, with 0.09 % sodium azide as preservative.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Prior to reconstitution store at 2-8 °C. Following reconstitution store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target
    BMP10 (Bone Morphogenetic Protein 10 (BMP10))
    Andere Bezeichnung
    BMP10 (BMP10 Produkte)
    Synonyme
    BMP10 antikoerper, si:dkey-13n15.5 antikoerper, Bmp10 antikoerper, BMP9 antikoerper, BMP-10 antikoerper, bone morphogenetic protein 10 antikoerper, BMP10 antikoerper, bmp10 antikoerper, LOC662386 antikoerper, Bmp10 antikoerper
    Hintergrund
    Bone morphogenetic protein-10 (BMP10) belongs to the transforming growth factor beta (TGFß) family. BMPs, named for their initial biological activity of inducing ectopic bone formation, have been linked to multiple steps of cardiac development. BMP10 is translated as a precursor protein (preproprotein) with N-terminal hydrophobic leader peptide followed by prodomain and the mature C-terminal region that is released after the cleavage at multibasic motif RXRR. Data strongly suggest that BMP10 is an essential component in modulating cardiomyocyte proliferation and maturation during cardiac ventricular development.Synonyms: BMP-10, Bone morphogenetic protein 10
    Gen-ID
    27302
    NCBI Accession
    NP_055297
    UniProt
    O95393
    Pathways
    Hormone Activity, Regulation of Muscle Cell Differentiation
Sie sind hier:
Kundenservice